Literature DB >> 25792226

A human surrogate model of itch utilizing the TRPA1 agonist trans-cinnamaldehyde.

Chris R Højland1, Hjalte H Andersen, Jeppe N Poulsen, Lars Arendt-Nielsen, Parisa Gazerani.   

Abstract

The thermoreceptive transient receptor potential ankyrin 1 (TRPA1) is important in the transmission of itch, and its agonist trans-cinnamaldehyde has occasionally been reported to be a pruritogen in humans. However, no studies have accurately quantified the capabilities of trans-cinnamaldehyde to induce itch and related dysesthetic sensations. The present study examined alterations in somatosensory and vasomotor parameters in response to topical trans-cinnamaldehyde 5% and vehicle (ethanol) in 24 healthy subjects. During the study the following parameters were recorded: itch area and intensity, hyperknesis, alloknesis, neurogenic flare, skin blood flow and temperature. Trans-cinnamaldehyde evoked moderate itch sensation, flare, hyperknesis and alloknesis (p < 0.001). Blood flow and skin temperature were elevated in the area of trans-cinnamaldehyde application (p < 0.001). Significant positive correlations were found between blood flow and skin temperature, itch area and blood flow, and itch area and skin temperature. Topical trans-cinnamaldehyde proved feasible as a human itch model with applicability in studying itch mechanisms or anti-pruritic drug profiling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25792226     DOI: 10.2340/00015555-2103

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  9 in total

Review 1.  Environmental risk factors and their role in the management of atopic dermatitis.

Authors:  Robert Kantor; Jonathan I Silverberg
Journal:  Expert Rev Clin Immunol       Date:  2016-07-28       Impact factor: 4.473

2.  Density-functional theory of the catnip molecule, nepetalactone.

Authors:  Syed Lal Badshah; Rabiya Jehan
Journal:  Mol Cell Biochem       Date:  2022-01-25       Impact factor: 3.396

3.  Cinnamaldehyde elicits itch behavior via TRPV1 and TRPV4 but not TRPA1.

Authors:  Dan Domocos; Taylor Follansbee; Amanda Nguyen; Tony Nguyen; Mirela I Carstens; Earl Carstens
Journal:  Itch (Phila)       Date:  2020-07-24

Review 4.  Skin neurogenic inflammation.

Authors:  Jae Eun Choi; Anna Di Nardo
Journal:  Semin Immunopathol       Date:  2018-04-30       Impact factor: 9.623

Review 5.  Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization.

Authors:  Chengjin Li; Hee Jin Kim; Seung Keun Back; Heung Sik Na
Journal:  Pflugers Arch       Date:  2021-07-10       Impact factor: 3.657

6.  A zebrafish and mouse model for selective pruritus via direct activation of TRPA1.

Authors:  Kali Esancy; Logan Condon; Jing Feng; Corinna Kimball; Andrew Curtright; Ajay Dhaka
Journal:  Elife       Date:  2018-03-21       Impact factor: 8.140

7.  Evaluating the association of TRPA1 gene polymorphisms with pain sensitivity: a protocol for an adaptive recall by genotype study.

Authors:  Aidan P Nickerson; Laura J Corbin; Nicholas J Timpson; Keith Phillips; Anthony E Pickering; James P Dunham
Journal:  BMC Med Genomics       Date:  2022-01-12       Impact factor: 3.063

Review 8.  Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects.

Authors:  Hao-Jui Weng; Quoc Thao Trang Pham; Chia-Wei Chang; Tsen-Fang Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19

9.  Considerable Variability in the Efficacy of 8% Capsaicin Topical Patches in the Treatment of Chronic Pruritus in 3 Patients with Notalgia Paresthetica.

Authors:  Hjalte H Andersen; Carsten Sand; Jesper Elberling
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.